Patents by Inventor Ryan Noyce

Ryan Noyce has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYNTHETIC CHIMERIC POXVIRUSES
    Publication number: 20260139233
    Abstract: The invention relates, in general, to synthetic chimeric poxviruses, compositions comprising such viruses, and the development and use of systems and methods for producing such synthetic chimeric poxviruses. The synthetic chimeric poxviruses are well suited for live virus vaccines and pharmaceutical formulations.
    Type: Application
    Filed: June 25, 2025
    Publication date: May 21, 2026
    Inventors: David Evans, Ryan Noyce, Seth Lederman
  • SYNTHETIC CHIMERIC POXVIRUSES
    Publication number: 20260022350
    Abstract: The invention relates, in general, to synthetic chimeric poxviruses, compositions comprising such viruses, and the development and use of systems and methods for producing such synthetic chimeric poxviruses. The synthetic chimeric poxviruses are well suited for live virus vaccines and pharmaceutical formulations.
    Type: Application
    Filed: June 25, 2025
    Publication date: January 22, 2026
    Inventors: David Evans, Ryan Noyce, Seth Lederman
  • Synthetic chimeric vaccinia virus
    Patent number: 12529036
    Abstract: The invention relates in various aspects to a synthetic chimeric vaccinia virus or compositions comprising such viruses, and the development and use of systems and methods for producing such synthetic chimeric vaccinia viruses. The synthetic chimeric vaccinia viruses are well suited, among others, as virus vaccines or to generate an oncolytic response and pharmaceutical formulations.
    Type: Grant
    Filed: May 2, 2019
    Date of Patent: January 20, 2026
    Assignee: TONIX PHARMA LIMITED
    Inventors: David Evans, Ryan Noyce, Seth Lederman
  • Synthetic chimeric poxviruses
    Patent number: 12365879
    Abstract: The invention relates, in general, to synthetic chimeric poxviruses, compositions comprising such viruses, and the development and use of systems and methods for producing such synthetic chimeric poxviruses. The synthetic chimeric poxviruses are well suited for live virus vaccines and pharmaceutical formulations.
    Type: Grant
    Filed: May 27, 2022
    Date of Patent: July 22, 2025
    Assignee: TONIX PHARMA LIMITED
    Inventors: David Evans, Ryan Noyce, Seth Lederman
  • SYNTHETIC CHIMERIC POXVIRUSES
    Publication number: 20230002741
    Abstract: The invention relates, in general, to synthetic chimeric poxviruses, compositions comprising such viruses, and the development and use of systems and methods for producing such synthetic chimeric poxviruses. The synthetic chimeric poxviruses are well suited for live virus vaccines and pharmaceutical formulations.
    Type: Application
    Filed: May 27, 2022
    Publication date: January 5, 2023
    Inventors: David Evans, Ryan Noyce, Seth Lederman
  • Synthetic chimeric poxviruses
    Patent number: 11345896
    Abstract: The invention relates, in general, to synthetic chimeric poxviruses, compositions comprising such viruses, and the development and use of systems and methods for producing such synthetic chimeric poxviruses. The synthetic chimeric poxviruses are well suited for live virus vaccines and pharmaceutical formulations.
    Type: Grant
    Filed: November 2, 2017
    Date of Patent: May 31, 2022
    Inventors: David Evans, Ryan Noyce, Seth Lederman
  • RECOMBINANT POXVIRUS BASED VACCINE AGAINST SARS-CoV-2 VIRUS
    Publication number: 20210260182
    Abstract: The invention relates in various aspects to a recombinant poxvirus comprising a nucleic acid encoding a SARS-CoV-2 virus protein, methods for producing such viruses and the use of such viruses. The recombinant poxviruses are well suited, among others, as protective virus vaccines against SARS-CoV-2 virus.
    Type: Application
    Filed: February 26, 2021
    Publication date: August 26, 2021
    Inventors: Seth Lederman, Scott J. Goebel, David Evans, Ryan Noyce
  • SYNTHETIC CHIMERIC VACCINIA VIRUS
    Publication number: 20210230560
    Abstract: The invention relates in various aspects to a synthetic chimeric vaccinia virus or compositions comprising such viruses, and the development and use of systems and methods for producing such synthetic chimeric vaccinia viruses. The synthetic chimeric vaccinia viruses are well suited, among others, as virus vaccines or to generate an oncolytic response and pharmaceutical formulations.
    Type: Application
    Filed: May 2, 2019
    Publication date: July 29, 2021
    Inventors: David Evans, Ryan Noyce, Seth Lederman
  • SYNTHETIC CHIMERIC POXVIRUSES
    Publication number: 20180251736
    Abstract: The invention relates, in general, to synthetic chimeric poxviruses, compositions comprising such viruses, and the development and use of systems and methods for producing such synthetic chimeric poxviruses. The synthetic chimeric poxviruses are well suited for live virus vaccines and pharmaceutical formulations.
    Type: Application
    Filed: November 2, 2017
    Publication date: September 6, 2018
    Inventors: David Evans, Ryan Noyce, Seth Lederman